Recent clinical studies emphasize the importance of early (<12 hours after onset) treatment of patients with acute ischemic stroke. Therapies have been proposed as being effective because of early clinical improvement. The frequency and degree of spontaneous improvement in such patients, however, is unknown. We prospectively evaluated the course of 29 patients (19 men, 10 women) aged 33-82 years who were seen < 12 hours after the onset of acute ischemic stroke. Seventeen patients were first evaluated <6 hours and the remaining patients at 6-12 hours after onset. All patients were examined using a modified National Institutes of Health Stroke Scale at baseline, 1,2,3, and 6 hours. No specific treatment for acute ischemic stroke was given during this time. Improvement (defined as a decrease of >2 points from baseline score) was noted at 1 hour in seven patients (24%). By 6 hours 15 patients (52%) had improved, 12 (41%) were unchanged, and two (7%) were worse. Our results suggest that spontaneous, often dramatic improvement occurs in patients with acute ischemic stroke and should be taken into consideration in the design of any trial of acute treatment. (Stroke 1990;21:1008-1012) D espite a burgeoning knowledge of its pathophysiology, 12 there is currently no generally accepted medical treatment for acute ischemic stroke. The conventional forms of therapy that exist are intended to reduce the secondary complications of a recent stroke or to prevent recurrences rather than to reverse acute, strokeinduced neurologic deficits. One factor allegedly affecting outcome in the management of acute cerebral ischemia is the delay in initiating therapy.
D
espite a burgeoning knowledge of its pathophysiology, 12 there is currently no generally accepted medical treatment for acute ischemic stroke. The conventional forms of therapy that exist are intended to reduce the secondary complications of a recent stroke or to prevent recurrences rather than to reverse acute, strokeinduced neurologic deficits. One factor allegedly affecting outcome in the management of acute cerebral ischemia is the delay in initiating therapy. 3 Before proclaiming the value of any acute therapeutic intervention, it is essential to assess the incidence of spontaneous improvement after ischemic stroke. Detailed evaluation of the degree of spontaneous recovery of neurologic function following an acute ischemic stroke is of the utmost importance in planning future trials of acute ischemic stroke therapy. For this reason we conducted a prospective pilot study to ascertain the natural history of patients hospitalized with acute ischemic stroke.
Subjects and Methods
From July 1, 1988 through November 30, 1989, consecutive patients >18 years old who had experienced a recent (within 12 hours) ischemic stroke of any subtype (cardioembolic [CE] or large-vessel atherothrombotic [LVAT] strokes, large-vessel atheroembolic [LVAE] or small-vessel/lacunar [SV] occlusions, or ischemic stroke of unknown cause [UC]) diagnosed based on our modification of the clinical criteria developed for the Harvard Cooperative Study Registry 4 were eligible for entry into the study. We excluded patients who presented with minimal neurologic deficit such that any improvement from baseline would be difficult to assess, those with resolved or resolving focal neurologic deficits at the time of the baseline examination, those in whom we were unable to establish with confidence the time of stroke onset, those who received intervening pharmacologic therapy (antithrombotic, platelet antiaggregant, thrombolytic, or hemorheologic agents; calcium channel blockers; drugs used for the treatment of cerebral edema; antihypertensive drugs), and those with hemorrhagic infarction or intracerebral or subarachnoid hemorrhage.
On entry into the study all patients were interviewed and had complete physical and neurologic examinations by the participating neurologists. Arterial hypertension was defined as a history of consis-tently elevated blood pressure of > 140/90 mm Hg or a history of elevated blood pressure treated with antihypertensive agents. Diabetes mellitus was defined according to the 1979 report of the National Diabetes Data Group. 5 Hypercholesterolemia was defined as a fasting cholesterol concentration greater than the 75th percentile for the adult US population (200 mg/dl). 6 Diagnostic studies included chest roentgenography, 12-lead electrocardiography, complete blood cell count with differential and platelet count, prothrombin time, partial thromboplastin time, blood glucose level, blood chemistries, erythrocyte sedimentation rate, luetic serology, urinalysis, and unenhanced brain computed tomography (CT). Echocardiography, ultrasound and Doppler studies of the carotid arteries, transcranial Doppler sonography, ultrafast (cine) CT of the heart, magnetic resonance imaging (MRI) of the brain, and cerebral angiography were optional.
Neurologic status was assessed using a modified National Institutes of Health (NIH) Stroke Scale 7 (Table 1) supplemented by the evaluation of proximal and distal muscle strength of the right and left arm (shoulder and wrist) and leg (hip and ankle) on a 0-5-point scale (0: full strength; 1: muscle moves joint against great resistance but is still not considered normal, considerable examiner effort is required to "break" the muscle; 2: muscle moves joint against resistance, increasing resistance without the examiner using great force is still successfully resisted; 3: muscle moves joint against gravity, any added resistance "breaks" the muscle; 4: muscle moves joint so long as gravity is eliminated; and 5: no trace of movement). The results for each part of the assessment were added to give the score, which could vary from 0 (no impairment) to 82 (maximum deficit). Patients were quantitatively evaluated without intervening pharmacologic therapy on entry (baseline) and 1, 2, 3, and 6 hours after entry by the same examiner. Improvement or worsening was defined as a change of >2 points from the baseline score.
We considered the percentage change in score (PRC) at 1, 2, 3, and 6 hours (e.g., PRC 3 =the absolute value of [3-hour score-baseline score] •*• baseline score x 100%) and the outcome (no change, improved, or worsened relative to baseline score) at 1 and 6 hours. Because of the small sample size and the multitude of comparisons, the results of statistical analyses (including probability values) should be thought of as descriptive rather than as careful tests of hypotheses. We expected 5% of our tests to indicate statistically significant differences even when there were no population differences. Because the data were not normally distributed, we used nonparametric statistical procedures: Spearman's rank correlation 8 to describe the associations among PRC values and the associations between age and PRC values; Wilcoxon's rank sum test and the experimental scores test for the dichotomous variables sex (male, female), time after onset to first evaluation (<6 hours, 6-12 hours), arterial hypertension (no, Results Thirty-two patients were eligible for entry into the study. Three patients were excluded; one had a prosthetic aortic valve and was receiving heparin, and the other two were drowsy, with periodic breathing patterns requiring immediate endotracheal intubation, mechanical hyperventilation, and osmotherapy (one had a dilated cardiomyopathy and a large left hemispheric cardioembolic stroke and the other had an extensive posterior fossa infarction secondary to a posttraumatic vertebrobasilar dissection). Therefore, the study group comprised 29 patients (19 men and 10 women) aged 33-82 (mean 64, median 66) years. Seventeen patients (58.6%) were first evaluated <6 hours and the other 12 (41.4%) 6-12 hours after the onset of symptoms. Seven patients (24.1%) had a history of stroke and six (20.7%) a history of TIAs. Nineteen patients (65.5%) had a history of heart disease, 14 (48.3%) had a history of arterial hypertension, 14 (48.3%) were cigarette smokers, seven (24.1%) had hypercholesterolemia, and five (17.2%) had diabetes mellitus. Eleven patients (37.9%) had CE strokes, six (20.7%) had LVAT strokes, six (20.7%) had LVAE occlusions, three (10.3%) had SV occlusions, and three (10.3%) had UC strokes. Fourteen patients (48.3%) were taking a platelet antiaggregating drug, usually aspirin, prior to stroke onset. Baseline CT was normal in 16 patients (55.2%) and showed hypodense areas or effacement of sulci thought to be new ischemic lesions in the remaining 13 (44.8%). Baseline MRI demonstrated areas of new infarction in 15 patients (51.7%) and was normal in six (20.7%); MRI was not performed in the other eight patients (27.6%).
The stroke subtype diagnosis, scores, and outcomes for the 29 patients are detailed in Table 2 . We found a 24% (seven patients) incidence of spontaneous improvement at 1 hour and a 52% (15 patients) incidence of spontaneous improvement in 6 hours. In addition, only 7% (two patients) had worsened while 41% (12 patients) had no change in neurologic score at 6 hours ( Figure 1 ).
Spearman's rank correlation coefficients among the PRC values are calculated. The closer in time the scores are measured, the more highly correlated the PRC values are: PRC! and PRQ, PRQ and PRC,, and PRQ and PRQ have correlation coefficients of 0.692, 0.899, and 0.845, respectively. Scores measured two time periods apart are less well correlated; PRC! and PRQ and PRQ and PRQ have correlation coefficients of 0.675 and 0.788, respectively. The scores measured three time periods apart (PRQ and PRQ) had the smallest correlation coefficient, 0.516. Each correlation coefficient had a probability value of < 0.001. PRQ is based on data from 28 patients (case 21 did not have a 2-hour evaluation).
Spearman's rank correlation was also used to describe the correlation between age and the four PRC values. The results are detailed in Table 3 . The correlation between age and PRC increases as the time after stroke increases. The results show no association between age and PRQ but a positive association at later times, with greater improvement shown by younger patients.
Comparisons of the PRC values of the two categories of the dichotomous variables showed greater median improvement in PRC over time in males, those first evaluated <6 hours after onset, those without hypertension, and those without diabetes mellitus; for P R Q , patients without diabetes improved significantly more than did diabetic patients, but although this trend continued, it was not significant for PRQ, PRQ, or PRQ. Only the differences in PRC for sex and hypertension were statistically significant. Median PRC values at 1, 2, 3, and 6 hours for the 19 men were -2. There were no significant differences among the five stroke subtypes with regard to PRC values.
Discussion
In recent decades, the attitude of much of the medical profession toward the treatment of patients with ischemic stroke has changed from hopelessness and outright nihilism to contagious optimism. This is partly explained by the significant advances made in our basic understanding of cerebral ischemia and the proliferation of a variety of biologically promising agents. However, much conflicting information has emerged from therapeutic trials of ischemic stroke in a variety of species, including humans. An impartial assessment of the published data reveals that effective therapy for acute ischemic stroke remains elusive. 9 Before addressing therapeutic issues, a better understanding of the degree of early and late recovery of function following ischemic neurologic deficits is needed. Furthermore, spontaneous improvement must be distinguished from improvement due to therapeutic intervention to determine the potential value of such therapy in these patients.
The aim of our prospective pilot study was to investigate the natural history of ischemic stroke during the acute phase. Evaluations were begun < 12 hours and were completed <18 hours after stroke onset. Patients with all subtypes of ischemic stroke were included so our results would be applicable to the entire population with stroke. Although many scales have been used to chart neurologic function following ischemic stroke, we used a modified NIH Stroke Scale supplemented with evaluation of proximal and distal limb strength. This NIH Stroke Scale has been validated by a number of investigators, confirming high interrater and test-retest reliabilities.
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The hypothesis that early spontaneous improvement is common in patients with ischemic stroke was tested by a methodical and careful assessment of the patients at 0,1, 2, 3, and 6 hours after entry within 12 PRC, percentage change in neurologic score at indicated hour relative to score at baseline. hours after the onset of acute ischemic stroke without any intervening therapy.
Our study suggests that a substantial number of patients with recent ischemic stroke demonstrate some degree of spontaneous improvement. We found that almost one fourth of the patients improved by 1 hour and that more than half improved by 6 hours. In addition, younger patients, men, and those without a history of arterial hypertension or diabetes mellitus improved to a greater degree. These preliminary findings suggest that spontaneous, often dramatic, improvement occurs soon after ischemic stroke and that this should be taken into consideration in the design of any trial of acute treatment.
